BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Komeil IA, El-Refaie WM, Gowayed MA, El-Ganainy SO, El Achy SN, Huttunen KM, Abdallah OY. Oral genistein-loaded phytosomes with enhanced hepatic uptake, residence and improved therapeutic efficacy against hepatocellular carcinoma. Int J Pharm 2021;601:120564. [PMID: 33812970 DOI: 10.1016/j.ijpharm.2021.120564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mm Shehata E, A Gowayed M, El-Ganainy SO, Sheta E, Sr Elnaggar Y, Abdallah OY. Pectin coated Nanostructured Lipid Carriers for Targeted Piperine Delivery to Hepatocellular Carcinoma. Int J Pharm 2022;:121712. [PMID: 35367582 DOI: 10.1016/j.ijpharm.2022.121712] [Reference Citation Analysis]
2 Khalil LM, Abdallah OY, Elnaggar YS, El-refaie WM. Novel dermal nanobilosomes with promising browning effect of adipose tissue for management of obesity. Journal of Drug Delivery Science and Technology 2022;74:103522. [DOI: 10.1016/j.jddst.2022.103522] [Reference Citation Analysis]
3 Zou Y, Zhong C, Hu Z, Duan S. MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis. Front Oncol 2021;11:743701. [PMID: 34676171 DOI: 10.3389/fonc.2021.743701] [Reference Citation Analysis]
4 Mahmoud K, Swidan S, El-nabarawi M, Teaima M. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01309-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jangid AK, Solanki R, Patel S, Pooja D, Kulhari H. Genistein encapsulated inulin-stearic acid bioconjugate nanoparticles: Formulation development, characterization and anticancer activity. Int J Biol Macromol 2022;206:213-21. [PMID: 35181329 DOI: 10.1016/j.ijbiomac.2022.02.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Limongi T, Susa F, Marini M, Allione M, Torre B, Pisano R, di Fabrizio E. Lipid-Based Nanovesicular Drug Delivery Systems. Nanomaterials (Basel) 2021;11:3391. [PMID: 34947740 DOI: 10.3390/nano11123391] [Reference Citation Analysis]
7 Elmowafy M, Shalaby K, Elkomy M, Alruwaili NK, Mostafa EM, Afzal M, Alharbi KS, Mohammed EF, Ali HM, Salama A, Barakat EH. Impact of highly phospholipid-containing lipid nanocarriers on oral bioavailability and pharmacodynamics performance of genistein. Pharmaceutical Development and Technology. [DOI: 10.1080/10837450.2022.2076111] [Reference Citation Analysis]
8 Javed Z, Khan K, Herrera-Bravo J, Naeem S, Iqbal MJ, Sadia H, Qadri QR, Raza S, Irshad A, Akbar A, Reiner Ž, Al-Harrasi A, Al-Rawahi A, Satmbekova D, Butnariu M, Bagiu IC, Bagiu RV, Sharifi-Rad J. Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. Cancer Cell Int 2021;21:388. [PMID: 34289845 DOI: 10.1186/s12935-021-02091-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Truong TH, Alcantara KP, Bulatao BPI, Sorasitthiyanukarn FN, Muangnoi C, Nalinratana N, Vajragupta O, Rojsitthisak P, Rojsitthisak P. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy. Carbohydrate Polymers 2022;288:119401. [DOI: 10.1016/j.carbpol.2022.119401] [Reference Citation Analysis]